{
    "id": 32056,
    "fullName": "NF2 G151fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "NF2 G151fs results in a change in the amino acid sequence of the Nf2 protein beginning at aa 151 of 595, likely resulting in premature truncation of the functional protein (UniProt.org). G151fs has not been biochemically characterized however, due to the effects of truncation mutations downstream of G151 (PMID: 19910496, PMID: 31257748), is predicted to lead to a loss of Nf2 protein function.",
            "references": [
                {
                    "id": 17214,
                    "pubMedId": 31257748,
                    "title": "Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31257748"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17549,
                    "pubMedId": 19910496,
                    "title": "Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19910496"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4771,
        "geneSymbol": "NF2",
        "terms": [
            "NF2",
            "ACN",
            "BANF",
            "SCH"
        ]
    },
    "variant": "G151fs",
    "createDate": "01/15/2020",
    "updateDate": "01/15/2020",
    "referenceTranscriptCoordinates": {
        "id": 186536,
        "transcript": "NM_000268",
        "gDna": "chr22:g.(29654659_29654660)",
        "cDna": "c.(451_450)",
        "protein": "p.G151fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19812,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, NF2 G151fs was identified in biopsies at disease progression after 26 months of Zykadia (ceritinib) treatment in a patient with inflammatory myofibroblastic tumor harboring ALK rearrangement (PMID: 31585938).",
            "molecularProfile": {
                "id": 34540,
                "profileName": "ALK rearrange NF2 G151fs"
            },
            "therapy": {
                "id": 789,
                "therapyName": "Ceritinib",
                "synonyms": null
            },
            "indication": {
                "id": 50905,
                "name": "inflammatory myofibroblastic tumor",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17546,
                    "pubMedId": 31585938,
                    "title": "Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31585938"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34539,
            "profileName": "NF2 G151fs",
            "profileTreatmentApproaches": [
                {
                    "id": 20152,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "NF2 G151fs"
                },
                {
                    "id": 20149,
                    "name": "mTOR Inhibitor",
                    "profileName": "NF2 G151fs"
                },
                {
                    "id": 20151,
                    "name": "EGFR Inhibitor (Pan)",
                    "profileName": "NF2 G151fs"
                },
                {
                    "id": 20150,
                    "name": "VEGFR Inhibitor (Pan)",
                    "profileName": "NF2 G151fs"
                },
                {
                    "id": 20148,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "NF2 G151fs"
                }
            ]
        },
        {
            "id": 34540,
            "profileName": "ALK rearrange NF2 G151fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186534,
            "transcript": "NM_181832",
            "gDna": "chr22:g.(29654659_29654660)",
            "cDna": "c.(451_450)",
            "protein": "p.G151fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186535,
            "transcript": "NM_016418",
            "gDna": "chr22:g.(29654659_29654660)",
            "cDna": "c.(451_450)",
            "protein": "p.G151fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186536,
            "transcript": "NM_000268",
            "gDna": "chr22:g.(29654659_29654660)",
            "cDna": "c.(451_450)",
            "protein": "p.G151fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 186537,
            "transcript": "NM_181825",
            "gDna": "chr22:g.(29654659_29654660)",
            "cDna": "c.(451_450)",
            "protein": "p.G151fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}